CRIS Projects Details -
Accept Cookies

Cookies: How we use information on our website:

We use cookies on our website to make it clear, useful and reliable. In order to achieve this and to provide certain personalised features we store a small amount
of data about you. Click Here to learn more. By navigating from the front page to other sections of our website, you are consenting to information being stored.


CRIS Projects Details

Project Details

 

Clozapine in combination with LAI

Lead Applicant Name :
Ebenezer Oloyede
Project Type :
Research
Approval Date :
10-Feb-2022
References :
Lay Summary :
Clozapine is the most effective antipsychotic, but up to 60% of patients treated with clozapine monotherapy will not or only partially respond to treatment. Furthermore, discontinuation rates are up to 60% within 2 years of treatment. To add to this, some patients experience severe withdrawal symptoms when stopping clozapine abruptly. There have been suggestions in the literature that the combination of clozapine with LAI in partial responders can minimize withdrawal symptoms, reduce relapse rates and health care utilization in terms of ED visits and number of hospital admissions - we aim to investigate this in SLaM.<br/>

< Back to search